Results 241 to 250 of about 257,826 (338)

Renal transplantation under cyclophosphamide. [PDF]

, 1972
Booth, AS, Groth, CG, Halgrimson, CG, Penn, I, Putnam, CW, Starzl, TE   +5 more
core  

The Optimal Timing and Duration of Daily G‐CSF for the Primary Prevention of Febrile Neutropenia in Breast Cancer Patients Undergoing Adjuvant TAC Chemotherapy

Asia-Pacific Journal of Clinical Oncology, EarlyView.
The study aimed to determine the optimal timing and duration of filgrastim administration for the primary prevention of febrile neutropenia (FN) in breast cancer patients undergoing adjuvant TAC chemotherapy. Our findings suggest that initiating daily filgrastim from Day 2 and continuing for 7 days optimizes toxicity reduction.
Zisun Kim, Sung Mo Hur, Jong Eun Lee, Sun Wook Han, Hae Il Jung, Sung Yong Kim, Jihyoun Lee, Cheol Wan Lim   +7 more
wiley   +1 more source

RESTORATION OF HEMATOPOIESIS IN DOGS BY INFUSION OF CRYOPRESERVED AUTOLOGOUS PERIPHERAL WHITE CELLS FOLLOWING BUSULFAN-CYCLOPHOSPHAMIDE TREATMENT

, 1975
Kim M. Debelak-Fehir, Robert B. Epstein
openalex   +1 more source

Effects of Huluan decotion on cyclophosphamide-induced autoimmune premature ovarian failure in murine models. [PDF]

J Tradit Chin Med
Guiling F, Xiaolin Z, Chengwan S, Panxiao LI, Abudula A.   +4 more
europepmc   +1 more source

CT‐P39 Compared With Reference Omalizumab in Chronic Spontaneous Urticaria: Results From a Double‐Blind, Randomized, Active‐Controlled, Phase 3 Study

Allergy, EarlyView.
This study investigated the therapeutic equivalence of CT‐P39 (an omalizumab biosimilar) and EU‐approved reference omalizumab (ref‐OMA) in patients with chronic spontaneous urticaria. Therapeutic equivalence between CT‐P39 and ref‑OMA (300 mg) was demonstrated by the primary endpoint – confidence intervals of the treatment difference in mean change ...
Sarbjit S. Saini, Marcus Maurer, Yevgeniya Dytyatkovska, Ewa Springer, Maria Ratkova, Borislava Krusheva, Chun Wook Park, Grazyna Pulka, Marta Chełmińska, Adam Reich, Sunghyun Kim, Keumyoung Ahn, Suyoung Kim, Sewon Lee, Jieun Ka, Jongho Kim, Clive Grattan   +16 more
wiley   +1 more source

Correction to: Management of adult patients with podocytopathies: an update from the ERA Immunonephrology Working Group. [PDF]

Nephrol Dial Transplant
europepmc   +1 more source

An Activation Likelihood Estimation Meta-Analysis of Voxel-Based Morphometry Studies of Chemotherapy-Related Brain Volume Changes in Breast Cancer. [PDF]

Cancers (Basel)
Utecht S, Gomez-Acevedo H, Bona J, van der Plas E, Prior F, Larson-Prior LJ.   +5 more
europepmc   +1 more source

Human asthenozoospermia: Update on genetic causes, patient management, and clinical strategies

Andrology, EarlyView.
Abstract Background In mammals, sperm fertilization potential relies on efficient progression within the female genital tract to reach and fertilize the oocyte. This fundamental property is supported by the flagellum, an evolutionarily conserved organelle, which contains dynein motor proteins that provide the mechanical force for sperm propulsion and ...
Emma Cavarocchi, Maëva Drouault, Joao C. Ribeiro, Violaine Simon, Marjorie Whitfield, Aminata Touré   +5 more
wiley   +1 more source

Cyclophosphamide in exacerbations of multiple sclerosis. Therapeutic trial and a strategy for pilot drug studies.

, 1975
David A. Drachman, Philip Y. Paterson, Rainer Schmidt, Rainer Spehlmann   +3 more
openalex   +1 more source

Protective effects of Bifidobacterium longum subsp. longum BL21 against cyclophosphamide-induced reproductive dysfunction in zebrafish. [PDF]

Sci Rep
Dong Y, Zhou J, Tian H, Gai Z, Zou K, Wei Q, Han M.   +6 more
europepmc   +1 more source